Rani Therapeutics Holdings, Inc.
RANI- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001856725
In the last 90 days, Rani Therapeutics Holdings, Inc. insiders filed 2 open-market purchases and 2 sales; 68 institutions reported holding it in 13F filings for Q2 2026, worth $34.7M in total; no superinvestor holds it.
Q3 2021 vs. Q2 2021
How the institutions holding Rani Therapeutics Holdings, Inc. changed between Q2 2021 and Q3 2021.
All holders in Q3 2021All holders in Q2 2021
| Measure | Q2 2021 | Q3 2021 | Change |
|---|---|---|---|
| Holders | 0 | 15 | +15 |
| Shares | 0 | 1.10M | +1.10M |
| Value | $0 | $19.6M | +$19.6M |
New holders (15)
Institutions that held Rani Therapeutics Holdings, Inc. at the end of Q3 2021 but not at the end of Q2 2021.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Nan Fung Group Holdings Ltd | 493,584 | $8.80M | 2.82% |
| Vanguard Group Inc | 283,213 | $5.05M | 0.00% |
| Caas Capital Management LP | 75,000 | $1.34M | 0.10% |
| Goldman Sachs Group Inc | 60,649 | $1.08M | 0.00% |
| Squarepoint Ops LLC | 50,000 | $891.0K | 0.01% |
| Stifel Financial Corp | 37,950 | $676.0K | 0.00% |
| Millennium Management LLC | 28,996 | $517.0K | 0.00% |
| Geode Capital Management, LLC | 21,639 | $385.0K | 0.00% |
| State Street Corp | 19,700 | $351.0K | 0.00% |
| Northern Trust Corp | 11,430 | $204.0K | 0.00% |
| Canton Hathaway, LLC | 10,000 | $178.0K | 0.05% |
| UBS Group AG | 3,070 | $55.0K | 0.00% |
| Bank of America Corp | 1,467 | $26.0K | 0.00% |
| Northwestern Mutual Wealth Management Co | 1,000 | $18.0K | 0.00% |
| Wells Fargo & Company | 40 | $1.00K | 0.00% |
Sold out (0)
Institutions that held Rani Therapeutics Holdings, Inc. at the end of Q2 2021 and filed for Q3 2021 without it.
None.